American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edition. American Psychiatric Association: Washington, DC
Antoine D, Huhn AS, Strain EC, Turner G, Jardot J, Hammond AS, Dunn KE (2021) Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine/naloxone. Am J Addict 30:83–87
Banks ML, Negus SS (2017) Insights from preclinical choice models on treating drug addiction. Trends Pharmacol Sci 38:181–194
Article CAS PubMed Google Scholar
Beylon GJ, Kaplan HL, Somer G, Busto UE, Sellers EM (2000) Comparative abuse liability of intravenously administered remifentanil and fentanyl. J Clin Pharmacol 20:597–606
Bodner RJ (2008) Endogenous opiates and behavior: 2007. Peptides 29:2292–2375
Center for Disease Control and Prevention (2022) Provisional Drug Overdose Death Counts. Accessed at https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
Chow JJ, Beckmann JS (2021) Remifentanil-food choice follows predictions of relative subjective value. Drug Alcohol Depend 218:108369
Article CAS PubMed Google Scholar
Ciccarone D (2021) The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry 34:344–350
Article PubMed PubMed Central Google Scholar
Cooper ZD, Truong NT, Shi YG, Woods JH (2008) Morphine deprivation increases self-administration of the fast and short-acting mu-opioid agonist remifentanil in the rat. J Pharmacol Exp Ther 326:920–929
Article CAS PubMed Google Scholar
Duthie DJ, Stevens JJ, Doyle AR, Baddoo HH, Gupta SK, Muir KT, Kirkham AJ (1997) Remifentanil and pulmonary extraction during and after cardiac anesthesia. Anesth Analg 84:740–744
Article CAS PubMed Google Scholar
Foltin RW, Haney M (2004) Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects. Pharmacol Biochem Behav 78:93–101
Article CAS PubMed Google Scholar
Gureckis TM, Love BC (2009) Learning in noise: dynamic decision-making in a variable environment. J Math Psychol 53:180–193
Article PubMed PubMed Central Google Scholar
Hay JL, White JM, Bochner F, Somogyi AA (2008) Antinociceptive effects of high dose remifentanil in male methadone-maintained patients. Eur J Pain 12:926–933
Article CAS PubMed Google Scholar
Huhn AS, Hobelmann JG, Oyler GA, Strain EC (2020) Protracted renal clearance of fentanyl in persons with opioid use disorder. Drug Alcohol Depend 214:108147
Article CAS PubMed PubMed Central Google Scholar
Joint Economic Committee (2022) Accessed at https://www.jec.senate.gov/public/_cache/files/67bced7f-4232-40ea-9263-f033d280c567/jec-cost-of-opioids-issue-brief.pdf
Ko MC, Terner J, Hursh S, Woods JH, Winger G (2002) Relative reinforcing effects of three opioids with different durations of action. J Pharmacol Exp Ther 301:698–704
Article CAS PubMed Google Scholar
Lile JA, Stoops WW, Glaser PEA, Hays LR, Rush CR (2011) Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. Drug Alcohol Depend 119:187–193
Article CAS PubMed PubMed Central Google Scholar
Lile JA, Stoops WW, Rush CR, Negus SS, Glaser PEA, Hatton KW, Hays LR (2016) Development of a translational model to screen medications for cocaine use disorder II: choice between cocaine and money in humans. Drug Alcohol Depend 165:111–119
Article PubMed PubMed Central Google Scholar
Lile JA, Johnson AR, Banks ML, Hatton KW, Hays LR, Nicholson KL, Poklis JL, Rayapati AO, Rush CR, Stoops WW, Negus SS (2020) Pharmacological validation of a translational model of cocaine use disorder: effects of d-amphetamine maintenance on choice between intravenous cocaine and a non-drug alternative in humans and rhesus monkeys. Exp Clin Psychopharmacol 28:169–180
Article CAS PubMed Google Scholar
Lofwall MR, Babalonis S, Nuzzo PA, Elayi SC, Walsh SL (2016) Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans. Drug Alcohol Depend 164:143–150
Article CAS PubMed PubMed Central Google Scholar
Martin TJ, Walker LE, Sizemore GM, Smith JE, Dworkin SI (1996) Within-session determination of dose-response curves for heroin self-administration in rats: comparison with between-session determination and effects of naltrexone. Drug Alcohol Depend 41:93–100
Article CAS PubMed Google Scholar
Martinez S, Jones JD, Brandt L, Campbell ANC, Abbott RA, Comer SD (2021) The increasing prevalence of fentanyl: a urinalysis-based study among individuals with opioid use disorder in New York City. Am J Addict 30:65–71
Miezin FM, Maccotta L, Ollinger JM, Petersen SE, Buckner RL (2000) Characterizing the hemodynamic response: effects of presentation rate, sampling procedure, and the possibility of ordering brain activity based on relative timing. NeuroImage 11:735–759
Article CAS PubMed Google Scholar
Moss RB, Carlo DJ (2019) Higher doses of naloxone are needed in the synthetic opioid era. Subst Abuse Treat Prev Policy 14:6
Article PubMed PubMed Central Google Scholar
Niv Y, Daniel R, Geana A, Gershman SJ, Leong YC, Radulescu A, Wilson RC (2015) Reinforcement learning in multidimensional environments relies on attention mechanisms. J Neurosci 35:8145–8157
Article CAS PubMed PubMed Central Google Scholar
Oxecta® Product Information (2013) King Pharmaceuticals Inc., Bristol, Tennessee 37620, USA
Panlilio LV, Secci ME, Schindler CW, Bradberry CW (2017) Choice between delayed food and immediate opioids in rats: treatment effects and individual differences. Psychopharmacology 234:3361–3373
Article CAS PubMed PubMed Central Google Scholar
Poldrack R, Mumford J, Nichols T (2011) Statistical modeling: single subject analysis. Handbook of functional MRI Data Analysis. Cambridge University Press, Cambridge, pp 70–99. doi:https://doi.org/10.1017/CBO9780511895029.006.
Smith AP, Beckmann JS (2021) Quantifying value-based determinants of drug and non-drug decision dynamics. Psychopharmacology 238:2037–2057
Stoops WW, Pike E, Hays LR, Glaser PE, Rush CR (2015) Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine. Pharmacol Biochem Behav 129:45–50
Article CAS PubMed Google Scholar
Stoops WW, Strickland JC, Hatton KW, Hays LR, Rayapati AO, Lile JA, Rush CR (2022) Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans. Pharmacol Biochem Behav 220:173466
Article CAS PubMed PubMed Central Google Scholar
Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, Marshall BDL, Tyndall M, Walsh S (2020) Opioid use disorder. Nat Rev Dis Primers 6:3
Sutton RS, Barto AG (1998) Reinforcement learning: an introduction. MIT Press, Cambridge, MA
Torralva R, Janowsky A (2019) Noradrenergic mechanisms in fentanyl-mediated rapid death explain failure of naloxone in the opioid crisis. J Pharmacol Exp Ther 371:453–475
Article CAS PubMed PubMed Central Google Scholar
Ultiva® Product Information (2001) Abbot Laboratories, North Chicago. IL 60064, USA
Vearrier D, Grundmann O (2021) Clinical pharmacology, toxicity and abuse potential of opioids. J Clin Pharmacol 61(Suppl 2):S70–S88
Volkow ND, Blanco C (2023) Fentanyl and other opioid use disorders: treatment and research needs. Am J Psychiatry 180:410–417
Wesson DR, Ling W (2003) The clinical opiate withdrawal scale. J Psychoact Drugs 35:253–259
Zernig G, Giacomuzzi S, Riemer Y, Wakonigg G, Sturm K, Saria A (2003) Intravenous drug injection habits: drug users’ self-reports versus researchers’ perception. Pharmacology 68:49–56
Comments (0)